RGL-305
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RGL-305, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: RGL-305+ Lymphoma + Exploratory Clinical Study [NA]